Lilly pledges $500M to South Korea biopharma industry, following Roche’s lead - Fierce Biotech
Lilly pledges $500M to South Korea biopharma industry, following Roche’s lead - Fierce Biotech
Body unavailable. Use the original source.
Lilly pledges $500M to South Korea biopharma industry, following Roche’s lead - Fierce Biotech
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.